SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 11.984
EU - Europa 4.596
AS - Asia 1.414
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 16
SA - Sud America 13
OC - Oceania 3
Totale 18.048
Nazione #
US - Stati Uniti d'America 11.960
PL - Polonia 980
SE - Svezia 928
UA - Ucraina 806
IT - Italia 714
CN - Cina 545
HK - Hong Kong 361
FI - Finlandia 304
TR - Turchia 291
BG - Bulgaria 165
DE - Germania 160
IE - Irlanda 157
GB - Regno Unito 138
SG - Singapore 130
FR - Francia 89
BE - Belgio 42
CH - Svizzera 25
CA - Canada 24
VN - Vietnam 21
EU - Europa 20
IN - India 16
NL - Olanda 14
HU - Ungheria 13
RU - Federazione Russa 13
KR - Corea 12
SN - Senegal 12
BR - Brasile 10
ES - Italia 8
HR - Croazia 7
JP - Giappone 7
RO - Romania 7
GR - Grecia 6
IR - Iran 6
ID - Indonesia 5
MY - Malesia 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
AT - Austria 3
NO - Norvegia 3
SI - Slovenia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CO - Colombia 2
IL - Israele 2
IQ - Iraq 2
LV - Lettonia 2
PK - Pakistan 2
TW - Taiwan 2
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 18.048
Città #
Woodbridge 1.571
Fairfield 1.454
Ann Arbor 1.374
Houston 1.354
Warsaw 977
Chandler 940
Ashburn 855
Jacksonville 739
Wilmington 697
Seattle 632
Cambridge 489
Hong Kong 360
Princeton 310
Izmir 275
Trieste 257
Beijing 178
Sofia 164
Dublin 157
Boardman 120
Dearborn 85
San Diego 69
Milan 68
Singapore 63
Bremen 58
Helsinki 50
Düsseldorf 43
Falls Church 43
Jinan 42
Brussels 40
Des Moines 36
Nanjing 28
Norwalk 26
Buffalo 25
Sacile 24
Washington 24
Chicago 23
Hefei 23
Verona 21
Bern 20
Dong Ket 18
Kunming 17
Fremont 16
Denver 15
Guangzhou 15
Mestre 15
Redwood City 15
Shenyang 15
Phoenix 14
Toronto 13
Dakar 12
Redmond 12
Budapest 10
Seoul 10
Columbus 9
Los Angeles 9
San Francisco 9
Shanghai 9
Auburn Hills 8
Edinburgh 8
Kocaeli 8
Port Coquitlam 8
São Paulo 8
Torre Del Greco 8
Fuzhou 7
Hebei 7
London 7
Pune 7
Tulsa 7
Cascina 6
Detroit 6
Grafing 6
Leawood 6
Nanchang 6
Philadelphia 6
Tappahannock 6
Zhengzhou 6
Andover 5
Boston 5
Changsha 5
Hangzhou 5
Taizhou 5
Tianjin 5
Wuhan 5
Zagreb 5
Amsterdam 4
Brno 4
Chengdu 4
Chongqing 4
Doncaster 4
Dongguan 4
Frankfurt Am Main 4
Hamburg 4
Indiana 4
Novara 4
Paris 4
Piemonte 4
Pieris 4
San Mateo 4
Tokyo 4
Clearwater 3
Totale 14.181
Nome #
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 331
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 307
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 301
Rational design of antirheumatic prodrugs specific for sites of inflammation 294
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 227
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 215
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 210
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 191
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 186
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 185
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 181
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 181
The gut as site of production of autoimmune antibodies. 179
Autoantibodies as predictors of disease. 176
Anti transglutaminase antibodies cause ataxia in mice. 176
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 176
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 174
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 173
Anti-transglutaminase antibodies and age. 171
null 166
Phage display technology for human monoclonal antibodies 166
null 163
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 162
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 160
Primer sets for cloning the human repertoire of T cell Receptor variable regions 159
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 155
A reliable screening procedure for coeliac disease in clinical practice. 155
Recombinant antibody selections by combining phage and yeast display 155
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 153
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 153
Dual sugar gut-permeability testing on blood drop in animal models. 150
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 149
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 149
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 145
Development of a novel rapid non-invasive screening test for coeliac disease. 143
An Air-well sparging minifermenter system for high-throughput protein production 143
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 142
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 142
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 141
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 141
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 140
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 138
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 132
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 132
Gluten ataxia: passive transfer in a mouse model. 131
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 131
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 131
Antibodies in proteomics I: generating antibodies 129
A definitive set of oligonucleotide primers for amplifying human V regions 129
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 129
Plasmid incompatibility: More compatible than previously thought? 128
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 126
Anti-idiotypic response in mice expressing human autoantibodies. 126
Prevalence of celiac disease among risk groups and the general population in USA 126
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 126
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 125
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 125
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 125
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 123
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 123
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 123
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 120
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 119
null 119
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 119
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 118
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 118
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 117
A deep-blue OLED-based biochip for protein microarray fluorescence detection 115
Recombinant renewable polyclonal antibodies 115
null 114
Rapid and simple dot immunobinding assay to detect anti human transglutaminase antibodies in coeliac disease 114
null 114
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 114
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 113
Human tissue transglutaminase ELISA: powerful massscreening diagnostic assay for coeliac disease 112
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 112
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 111
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 111
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice 111
Profiling celiac disease antibody repertoire 110
Binders based on dimerised immunoglobulin VH domains 109
Antibodies to transglutaminasefrom phage display libraries 108
Mucosal tissue transglutaminase expression in celiac disease 108
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 106
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 106
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 105
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 103
null 100
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 99
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 99
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 99
Protective role of anti-idiotypic network in celiac disease prone subjects 98
null 97
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 97
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 97
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 97
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 96
Simple scale-up of recombinant antibody production using an UCOE containing vector 96
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial caco-2 cells 96
Totale 14.136
Categoria #
all - tutte 45.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019349 0 0 0 0 0 0 0 0 0 0 0 349
2019/20204.032 217 199 226 702 277 571 413 450 351 228 267 131
2020/20212.622 257 178 260 310 204 276 147 219 144 276 105 246
2021/20221.709 87 114 68 139 65 157 74 55 207 179 140 424
2022/20232.673 257 331 215 382 267 485 26 241 290 25 116 38
2023/20241.424 81 78 73 94 155 195 225 271 22 36 133 61
Totale 18.539